Evidence map›Paper›PMID 35008887›Full record

ReviewInternational journal of molecular sciences2021

The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment.

Siarhei A Dabravolski, Nikita G Nikiforov, Alexander D Zhuravlev, Nikolay A Orekhov, Liudmila M Mikhaleva, Alexander N Orekhov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. CouldDiagnostics (Basel, Switzerland) · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Siarhei A DabravolskiDepartment of Clinical Diagnostics, Vitebsk State Academy of Veterinary Medicine [UO VGAVM], 7/11 Dovatora Street, 210026 Vitebsk, Belarus.ORCID 0000-0002-0547-6310
Nikita G NikiforovAP Avtsyn Research Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia.
Alexander D ZhuravlevAP Avtsyn Research Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia.
Nikolay A OrekhovInstitute for Atherosclerosis Research, Osennyaya Street 4-1-207, 121609 Moscow, Russia.
Liudmila M MikhalevaAP Avtsyn Research Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia.
Alexander N OrekhovInstitute for Atherosclerosis Research, Osennyaya Street 4-1-207, 121609 Moscow, Russia.ORCID 0000-0002-3318-4681
Institute for Atherosclerosis Research · RUResearch Institute of Human Morphology · RUInstitute of Gene Biology · RUVitebsk State Academy of Veterinary Medicine · BY

Funding

Russian Science Foundation 20-15-00337
6 · The paper itself

Abstract

Thyroid cancer (TC) is the most common type of endocrine malignancy. Tumour formation, progression, and metastasis greatly depend on the efficacy of mitochondria-primarily, the regulation of mitochondria-mediated apoptosis, Ca

Indexed as

MitochondriaThyroid NeoplasmsApoptosisCarcinogenesisHumansMitophagyReactive Oxygen SpeciesReactive Oxygen Speciesapoptosismitochondrial DNA mutationmitochondrial dynamicsmitophagythyroid cancer

Identifiers

PMID35008887
PMCPMC8745127
OpenAlexW4205217402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.